Advertisement

Topics

Latest "Influenza Vaccination At A Reduced Dose Using Mesotherapy In HIV/AIDS Patients At The Hadassah AIDS Center, Jerusalem" News Stories

19:51 EST 18th February 2019 | BioPortfolio

Here are the most relevant search results for "Influenza Vaccination At A Reduced Dose Using Mesotherapy In HIV/AIDS Patients At The Hadassah AIDS Center, Jerusalem" found in our extensive news archives from over 250 global news sources.

More Information about Influenza Vaccination At A Reduced Dose Using Mesotherapy In HIV/AIDS Patients At The Hadassah AIDS Center, Jerusalem on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Influenza Vaccination At A Reduced Dose Using Mesotherapy In HIV/AIDS Patients At The Hadassah AIDS Center, Jerusalem for you to read. Along with our medical data and news we also list Influenza Vaccination At A Reduced Dose Using Mesotherapy In HIV/AIDS Patients At The Hadassah AIDS Center, Jerusalem Clinical Trials, which are updated daily. BioPortfolio also has a large database of Influenza Vaccination At A Reduced Dose Using Mesotherapy In HIV/AIDS Patients At The Hadassah AIDS Center, Jerusalem Companies for you to search.

Showing "Influenza Vaccination Reduced Dose Using Mesotherapy AIDS Patients" News Articles 1–25 of 23,000+

Monday 18th February 2019

Single-dose CRISPR–Cas9 therapy extends lifespan of mice with Hutchinson–Gilford progeria syndrome


Inventiva Announces Results From Phase IIb Clinical Trial with Lanifibranor in Systemic Sclerosis

Inventiva Announces Results From Phase IIb Clinical Trial with Lanifibranor in Systemic Sclerosis Primary endpoint of the trial was not met, no statistically significant difference between the placebo and lanifibranor treated groups for the primary outcome  Favorable safety profile of lanifibranor observed  Decision to discontinue further developments in the treatment of ...

Physicians’ Education Resource® Presents New York GU™: 12th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies

The congress will focus on key clinical topics in the management of genitourinary malignancies Physicians’ Education Resource® (PER®), a leading resource for continuing medical education (CME), will host the 2019 New York GU™: 12th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies meeting on March 15 and 16 ...


Muscle Maker Grill Introduces the Impossible Burger

Fast-Casual Brand Adds Plant-Based Burger to the Burger Bar Lineup Muscle Maker Grill, the fast-casual restaurant brand, which promotes a healthy lifestyle by offering nutritious alternatives to traditional dishes, today announced the addition of the plant-based Impossible Burger, which delivers unprecedented taste, nutrition and versatility com...

‘Off-the-shelf’ CAR-Ts have an important role to play – but are they ready for prime time?

Allogeneic CAR-Ts could serve an important niche – particularly for patients who can’t receive autologous CAR-Ts – but the earliness of the data makes conclusions tough to draw.

Selective delipidation of Mycobacterium bovis BCG enables direct pulmonary vaccination and enhances protection against Mycobacterium tuberculosis

As medical costs mount, Japan to weigh cost-effectiveness in setting drug prices

Japanese doctor Yasushi Goto remembers prescribing the cancer drug Opdivo to an octogenarian and wondering whether taxpayers might object to helping fund treatment, which at the time cost hundreds of thousands of dollars, for patients in their twilig...

Glooko Launches Integration with Novo Nordisk Insulin Pen

Today, Glooko announced the launch of their integration with the Novo Nordisk connected insulin pen on our diasend® platform and the release of their Annual Diabetes Report.  With diasend, doctors were able to see and advise patients based on recorded insulin dose data from connected Novo Nordisk pens without having to invest additional time. Now, to raise the bar ... Read More

Brexit: GPs are told to resist patients’ requests to overprescribe

GPs should resist requests from patients to issue longer repeat prescriptions in the run up to Brexit and should liaise closely with pharmacists if they are concerned about shortages of specific...

AXA Hong Kong announces VHIS Perception Survey Findings

Over 80% of Hong Kong people consider participating Near 40% of respondents underestimate the medical expenses[1] AXA Hong Kong expands healthcare plan coverage to meet market needs HONG KONG, Feb. 18, 2019 /PRNewswire/ -- The Hong Kong public health care system is at the brink of saturation, coupled with the se...

CB-839 in combination with cabozantinib in patients with clear cell and papillary metastatic renal cell cancer

Prof Funda Meric-Bernstam speaks to ecancer at the 2019 ASCO Genitourinary Cancers Symposium about a study looking at the combination of CB-839 with cabozantinib in patients with clear cell and papillary metastatic renal cell cancer. She explains that...

Options Shift Paradigm of Locally Advanced HER2+ Breast Cancer

Theresa Shao, MD, discusses the neoadjuvant and adjuvant findings with pertuzumab as well as the adjuvant use of neratinib in patients with locally advanced HER2-positive breast cancer.

Healthcare Analytics is Paving Its Way Into the Future of Healthcare - Download Quantzig’s Free Resource to Know More!

Quantzig, a leading analytics advisory firm that delivers customized analytics solutions, has announced the completion of their free supplement on the roadmap to healthcare analytics. Amidst the skyrocketing healthcare costs, companies in the

Quantitative Analysis of CT Images in Patients with Pyrrolizidine Alkaloid-Induced Sinusoidal Obstruction Syndrome

KEYNOTE-365 Cohort A: Pembrolizumab plus olaparib in docetaxel-pretreated patients with mCRPC

Prof Evan Yu speaks to ecancer at the 2019 ASCO Genitourinary Cancers Symposium about Cohort A of the KEYNOTE-365 study which looked at the combination of pembrolizumab plus olaparib in docetaxel-pretreated patients with metastatic castrate-resistant...

NHS rolls out digital prescription prepayment certificates following successful pilot

Patients are now able to apply online for an instant digital prescription prepayment certificate (PPC) following a successful national pilot.

Global CAR-T Cell Therapy Market Size, Forecasts, Trials & Trends 2019: Increasing Investments, Major Acquisitions and Large IPOs Driving The Future – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global CAR-T Cell Therapy Market – Market Size, Forecasts, Trials & Trends” report has been added to ResearchAndMarkets.com’s offering. CAR-T cell therapy is a remarkably promising treatment for cancer patients. This emerging treatment represents one of the biggest … Continue reading →

Registration studies — when should patients be deemed ineligible for aggressive therapy?

Pay for Performance Works: HealthLeaders Media

(MedPage Today) -- Also, how to prevent unplanned hospitalization for cancer patients

Vizient Endorses ACE Kids Act to Support Complex Care Options for Pediatric Patients

Vizient today announced its support for the Advancing Care for Exceptional (ACE) Kids Act. The bipartisan ACE Kids Act would expand care options and promote enhanced care coordination for children who have complex medical needs. In letters to the lead sponsors in the House and Senate, Vizient has offered our formal endorsement of the ACE Kids Act. ...

Multimodality Approach Best for CNS Disease in NSCLC

Sarah B. Goldberg, MD, MPH, sheds light on the complex treatment paradigm for patients with lung cancer who have central nervous system metastases and highlights emerging treatment strategies for those with mesothelioma.

EchoNous Steps Upward with Release of Highly Reliable, All-Electronic Bladder Scanning Tool with State-of-the-Art Deep Learning Algorithm

EchoNous, an innovator focused on delivering intelligent medical tools, announces the release of EchoNous Bladder™, a highly reliable, all-electronic, non-mechanical, bladder scanning tool for nurses. To help nurses quickly determine bladder volume of patients, EchoNous Bladder combines data-rich fanning, a state-of-the-

Esserman Helps Push Breast Cancer Prevention Beyond Routine Screenings

Laura J. Esserman, MD, MBA, a 2018 Giants of Cancer Care® award winner in the Cancer Diagnostics category led the way in designing the I-SPY clinical trials, a groundbreaking effort to match patients with breast cancer to potential therapies based on molecular drivers of disease. She also has advocated for a greater understanding of the biological drivers of breast cancer, rather than relying ...

Visit-to-visit systolic blood pressure variability in patients with ST-elevation myocardial infarction predicts long-term cardiovascular outcomes

Very early marker of cardiac damage triggered by cancer treatment

Researchers have identified a very early marker of cardiac damage in patients undergoing therapy with anthracyclines, a family of drugs commonly used to treat cancer. This finding will enable the early diagnosis of the cardiotoxicity associated with this group of widely used chemotherapy drugs.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks